Screening of β-secretase and acetylcholinesterase inhibitors from plant resources

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

John M. Ringman, Sally A. Frautschy, Edmond Teng et al. · Alzheimer s Research & Therapy · 2012 · 529 citations · Full text

Medicine, Neurology, Pharmacology +17

A rapid TLC bioautographic method for the detection of acetylcholinesterase and butyrylcholinesterase inhibitors in plants

A. Marston, Jonathan Kissling, K. Hostettmann · Phytochemical Analysis · 2002 · 345 citations

Life Sciences, Biochemistry, Pharmacology +12

Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study

Samantha Rogers, Rachelle S. Doody, Raymond Pratt et al. · European Neuropsychopharmacology · 2000 · 268 citations

Medicine, Pharmacology, Psychiatry +15

3-Year Study of Donepezil Therapy in Alzheimer’s Disease: Effects of Early and Continuous Therapy

Bengt Winblad, Anders Wimo, Knut Engedal et al. · Dementia and Geriatric Cognitive Disorders · 2006 · 174 citations

Medicine, Pharmacotherapy, Psychiatry +17

The novel β‐secretase inhibitor KMI‐429 reduces amyloid β peptide production in amyloid precursor protein transgenic and wild‐type mice

Masashi Asai, Chinatsu Hattori, Nobuhisa Iwata et al. · Journal of Neurochemistry · 2005 · 141 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17